Label: THEOPHYLLINE tablet, extended release

  • NDC Code(s): 70771-1782-1, 70771-1783-1
  • Packager: Zydus Lifesciences Limited
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated May 22, 2024

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    Theophylline extended-release tablets, 300 mg

    100 Tablets

    NDC 70771-1782-1

    Rx only

    Theophylline Extended-Release Tablets 300mg

    Theophylline extended-release tablets, 450 mg

    100 Tablets

    NDC 70771-1783-1

    Rx only

    Theophylline Extended-Release Tablets 450 mg
  • INGREDIENTS AND APPEARANCE
    THEOPHYLLINE 
    theophylline tablet, extended release
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70771-1782
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    THEOPHYLLINE ANHYDROUS (UNII: 0I55128JYK) (THEOPHYLLINE ANHYDROUS - UNII:0I55128JYK) THEOPHYLLINE ANHYDROUS300 mg
    Inactive Ingredients
    Ingredient NameStrength
    HYPROMELLOSE 2208 (100 MPA.S) (UNII: B1QE5P712K)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    POVIDONE (UNII: FZ989GH94E)  
    Product Characteristics
    ColorWHITE (off white) Score2 pieces
    ShapeCAPSULE (biconvex) Size14mm
    FlavorImprint Code 7;28
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70771-1782-1100 in 1 BOTTLE; Type 0: Not a Combination Product05/25/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21806305/25/2024
    THEOPHYLLINE 
    theophylline tablet, extended release
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70771-1783
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    THEOPHYLLINE ANHYDROUS (UNII: 0I55128JYK) (THEOPHYLLINE ANHYDROUS - UNII:0I55128JYK) THEOPHYLLINE ANHYDROUS450 mg
    Inactive Ingredients
    Ingredient NameStrength
    HYPROMELLOSE 2208 (100 MPA.S) (UNII: B1QE5P712K)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    POVIDONE (UNII: FZ989GH94E)  
    Product Characteristics
    ColorWHITE (off white) Score2 pieces
    ShapeCAPSULE (biconvex) Size19mm
    FlavorImprint Code 7;29
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70771-1783-1100 in 1 BOTTLE; Type 0: Not a Combination Product05/25/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21806305/25/2024
    Labeler - Zydus Lifesciences Limited (918596198)
    Establishment
    NameAddressID/FEIBusiness Operations
    Zydus Lifesciences Limited863362789ANALYSIS(70771-1782, 70771-1783) , MANUFACTURE(70771-1782, 70771-1783)